Global Clinical Research Organisation (CRO) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Clinical Research Organisation (CRO) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 120

Published Date: 14 Jan 2022

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Clinical Research Organisation (CRO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Clinical Research Organisation (CRO) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical Company accounting for % of the Clinical Research Organisation (CRO) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Small molecules segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Clinical Research Organisation (CRO) include Charles River Laboratories, IQVIA, LabCorp, Domainex, and Evotec AG, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Clinical Research Organisation (CRO) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Small molecules
Biologics

Market segment by Application, can be divided into
Pharmaceutical Company
Research Institute
Other

Market segment by players, this report covers
Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Clinical Research Organisation (CRO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Clinical Research Organisation (CRO), with revenue, gross margin and global market share of Clinical Research Organisation (CRO) from 2019 to 2022.
Chapter 3, the Clinical Research Organisation (CRO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Clinical Research Organisation (CRO) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Clinical Research Organisation (CRO) research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Clinical Research Organisation (CRO)
1.2 Classification of Clinical Research Organisation (CRO) by Type
1.2.1 Overview: Global Clinical Research Organisation (CRO) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Clinical Research Organisation (CRO) Revenue Market Share by Type in 2021
1.2.3 Small molecules
1.2.4 Biologics
1.3 Global Clinical Research Organisation (CRO) Market by Application
1.3.1 Overview: Global Clinical Research Organisation (CRO) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Other
1.4 Global Clinical Research Organisation (CRO) Market Size & Forecast
1.5 Global Clinical Research Organisation (CRO) Market Size and Forecast by Region
1.5.1 Global Clinical Research Organisation (CRO) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Clinical Research Organisation (CRO) Market Size by Region, (2017-2022)
1.5.3 North America Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.5.4 Europe Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.5.6 South America Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Clinical Research Organisation (CRO) Market Drivers
1.6.2 Clinical Research Organisation (CRO) Market Restraints
1.6.3 Clinical Research Organisation (CRO) Trends Analysis

2 Company Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business
2.1.3 Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
2.1.4 Charles River Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Charles River Laboratories Recent Developments and Future Plans
2.2 IQVIA
2.2.1 IQVIA Details
2.2.2 IQVIA Major Business
2.2.3 IQVIA Clinical Research Organisation (CRO) Product and Solutions
2.2.4 IQVIA Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 IQVIA Recent Developments and Future Plans
2.3 LabCorp
2.3.1 LabCorp Details
2.3.2 LabCorp Major Business
2.3.3 LabCorp Clinical Research Organisation (CRO) Product and Solutions
2.3.4 LabCorp Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 LabCorp Recent Developments and Future Plans
2.4 Domainex
2.4.1 Domainex Details
2.4.2 Domainex Major Business
2.4.3 Domainex Clinical Research Organisation (CRO) Product and Solutions
2.4.4 Domainex Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Domainex Recent Developments and Future Plans
2.5 Evotec AG
2.5.1 Evotec AG Details
2.5.2 Evotec AG Major Business
2.5.3 Evotec AG Clinical Research Organisation (CRO) Product and Solutions
2.5.4 Evotec AG Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Evotec AG Recent Developments and Future Plans
2.6 Genscript Biotech
2.6.1 Genscript Biotech Details
2.6.2 Genscript Biotech Major Business
2.6.3 Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
2.6.4 Genscript Biotech Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Genscript Biotech Recent Developments and Future Plans
2.7 GVK Biosciences
2.7.1 GVK Biosciences Details
2.7.2 GVK Biosciences Major Business
2.7.3 GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
2.7.4 GVK Biosciences Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 GVK Biosciences Recent Developments and Future Plans
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
2.8.4 Aurobindo Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Aurobindo Pharma Recent Developments and Future Plans
2.9 Eurofins Scientific
2.9.1 Eurofins Scientific Details
2.9.2 Eurofins Scientific Major Business
2.9.3 Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
2.9.4 Eurofins Scientific Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Eurofins Scientific Recent Developments and Future Plans
2.10 Reprocell
2.10.1 Reprocell Details
2.10.2 Reprocell Major Business
2.10.3 Reprocell Clinical Research Organisation (CRO) Product and Solutions
2.10.4 Reprocell Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Reprocell Recent Developments and Future Plans
2.11 Dalton Pharma
2.11.1 Dalton Pharma Details
2.11.2 Dalton Pharma Major Business
2.11.3 Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
2.11.4 Dalton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Dalton Pharma Recent Developments and Future Plans
2.12 NovAliX
2.12.1 NovAliX Details
2.12.2 NovAliX Major Business
2.12.3 NovAliX Clinical Research Organisation (CRO) Product and Solutions
2.12.4 NovAliX Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 NovAliX Recent Developments and Future Plans
2.13 Jubilant Biosys
2.13.1 Jubilant Biosys Details
2.13.2 Jubilant Biosys Major Business
2.13.3 Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
2.13.4 Jubilant Biosys Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Jubilant Biosys Recent Developments and Future Plans
2.14 Lupin Pharmaceuticals
2.14.1 Lupin Pharmaceuticals Details
2.14.2 Lupin Pharmaceuticals Major Business
2.14.3 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
2.14.4 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Lupin Pharmaceuticals Recent Developments and Future Plans
2.15 Piramal Pharma
2.15.1 Piramal Pharma Details
2.15.2 Piramal Pharma Major Business
2.15.3 Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
2.15.4 Piramal Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Piramal Pharma Recent Developments and Future Plans
2.16 Sun Pharmaceutical
2.16.1 Sun Pharmaceutical Details
2.16.2 Sun Pharmaceutical Major Business
2.16.3 Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
2.16.4 Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Sun Pharmaceutical Recent Developments and Future Plans
2.17 Sai Ganga Panakeia
2.17.1 Sai Ganga Panakeia Details
2.17.2 Sai Ganga Panakeia Major Business
2.17.3 Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
2.17.4 Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Sai Ganga Panakeia Recent Developments and Future Plans
2.18 Vitas Pharma
2.18.1 Vitas Pharma Details
2.18.2 Vitas Pharma Major Business
2.18.3 Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
2.18.4 Vitas Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Vitas Pharma Recent Developments and Future Plans
2.19 Pharmaron Beijing
2.19.1 Pharmaron Beijing Details
2.19.2 Pharmaron Beijing Major Business
2.19.3 Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
2.19.4 Pharmaron Beijing Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Pharmaron Beijing Recent Developments and Future Plans
2.20 WuXi AppTec
2.20.1 WuXi AppTec Details
2.20.2 WuXi AppTec Major Business
2.20.3 WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
2.20.4 WuXi AppTec Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 WuXi AppTec Recent Developments and Future Plans
2.21 Asymchem Laboratories
2.21.1 Asymchem Laboratories Details
2.21.2 Asymchem Laboratories Major Business
2.21.3 Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
2.21.4 Asymchem Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Asymchem Laboratories Recent Developments and Future Plans
2.22 Porton Pharma
2.22.1 Porton Pharma Details
2.22.2 Porton Pharma Major Business
2.22.3 Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
2.22.4 Porton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Porton Pharma Recent Developments and Future Plans
2.23 ChemPartner
2.23.1 ChemPartner Details
2.23.2 ChemPartner Major Business
2.23.3 ChemPartner Clinical Research Organisation (CRO) Product and Solutions
2.23.4 ChemPartner Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23.5 ChemPartner Recent Developments and Future Plans
2.24 Hangzhou Tigermed
2.24.1 Hangzhou Tigermed Details
2.24.2 Hangzhou Tigermed Major Business
2.24.3 Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
2.24.4 Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24.5 Hangzhou Tigermed Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Clinical Research Organisation (CRO) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Clinical Research Organisation (CRO) Players Market Share in 2021
3.2.2 Top 10 Clinical Research Organisation (CRO) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Clinical Research Organisation (CRO) Players Head Office, Products and Services Provided
3.4 Clinical Research Organisation (CRO) Mergers & Acquisitions
3.5 Clinical Research Organisation (CRO) New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Clinical Research Organisation (CRO) Revenue and Market Share by Type (2017-2022)
4.2 Global Clinical Research Organisation (CRO) Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
5.1 Global Clinical Research Organisation (CRO) Revenue Market Share by Application (2017-2022)
5.2 Global Clinical Research Organisation (CRO) Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
6.1 North America Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
6.2 North America Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
6.3 North America Clinical Research Organisation (CRO) Market Size by Country
6.3.1 North America Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
6.3.2 United States Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
6.3.3 Canada Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
6.3.4 Mexico Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
7.1 Europe Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
7.2 Europe Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
7.3 Europe Clinical Research Organisation (CRO) Market Size by Country
7.3.1 Europe Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
7.3.2 Germany Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
7.3.3 France Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
7.3.5 Russia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
7.3.6 Italy Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
8.2 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
8.3 Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region
8.3.1 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Region (2017-2028)
8.3.2 China Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.3 Japan Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.4 South Korea Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.5 India Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.7 Australia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
9.1 South America Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
9.2 South America Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
9.3 South America Clinical Research Organisation (CRO) Market Size by Country
9.3.1 South America Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
9.3.2 Brazil Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
9.3.3 Argentina Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
10.2 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
10.3 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country
10.3.1 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
10.3.2 Turkey Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
10.3.4 UAE Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Clinical Research Organisation (CRO) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Clinical Research Organisation (CRO) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Clinical Research Organisation (CRO) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Clinical Research Organisation (CRO) Revenue (USD Million) by Region (2017-2022)
Table 5. Global Clinical Research Organisation (CRO) Revenue Market Share by Region (2023-2028)
Table 6. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Charles River Laboratories Major Business
Table 8. Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
Table 9. Charles River Laboratories Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. IQVIA Corporate Information, Head Office, and Major Competitors
Table 11. IQVIA Major Business
Table 12. IQVIA Clinical Research Organisation (CRO) Product and Solutions
Table 13. IQVIA Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. LabCorp Corporate Information, Head Office, and Major Competitors
Table 15. LabCorp Major Business
Table 16. LabCorp Clinical Research Organisation (CRO) Product and Solutions
Table 17. LabCorp Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Domainex Corporate Information, Head Office, and Major Competitors
Table 19. Domainex Major Business
Table 20. Domainex Clinical Research Organisation (CRO) Product and Solutions
Table 21. Domainex Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Evotec AG Corporate Information, Head Office, and Major Competitors
Table 23. Evotec AG Major Business
Table 24. Evotec AG Clinical Research Organisation (CRO) Product and Solutions
Table 25. Evotec AG Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Genscript Biotech Corporate Information, Head Office, and Major Competitors
Table 27. Genscript Biotech Major Business
Table 28. Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
Table 29. Genscript Biotech Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. GVK Biosciences Corporate Information, Head Office, and Major Competitors
Table 31. GVK Biosciences Major Business
Table 32. GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
Table 33. GVK Biosciences Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Aurobindo Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Aurobindo Pharma Major Business
Table 36. Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 37. Aurobindo Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 39. Eurofins Scientific Major Business
Table 40. Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
Table 41. Eurofins Scientific Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Reprocell Corporate Information, Head Office, and Major Competitors
Table 43. Reprocell Major Business
Table 44. Reprocell Clinical Research Organisation (CRO) Product and Solutions
Table 45. Reprocell Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Dalton Pharma Corporate Information, Head Office, and Major Competitors
Table 47. Dalton Pharma Major Business
Table 48. Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 49. Dalton Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. NovAliX Corporate Information, Head Office, and Major Competitors
Table 51. NovAliX Major Business
Table 52. NovAliX Clinical Research Organisation (CRO) Product and Solutions
Table 53. NovAliX Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Jubilant Biosys Corporate Information, Head Office, and Major Competitors
Table 55. Jubilant Biosys Major Business
Table 56. Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
Table 57. Jubilant Biosys Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Lupin Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. Lupin Pharmaceuticals Major Business
Table 60. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
Table 61. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Piramal Pharma Corporate Information, Head Office, and Major Competitors
Table 63. Piramal Pharma Major Business
Table 64. Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 65. Piramal Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 67. Sun Pharmaceutical Major Business
Table 68. Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
Table 69. Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Sai Ganga Panakeia Corporate Information, Head Office, and Major Competitors
Table 71. Sai Ganga Panakeia Major Business
Table 72. Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
Table 73. Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Vitas Pharma Corporate Information, Head Office, and Major Competitors
Table 75. Vitas Pharma Major Business
Table 76. Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 77. Vitas Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Pharmaron Beijing Corporate Information, Head Office, and Major Competitors
Table 79. Pharmaron Beijing Major Business
Table 80. Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
Table 81. Pharmaron Beijing Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. WuXi AppTec Corporate Information, Head Office, and Major Competitors
Table 83. WuXi AppTec Major Business
Table 84. WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
Table 85. WuXi AppTec Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Asymchem Laboratories Corporate Information, Head Office, and Major Competitors
Table 87. Asymchem Laboratories Major Business
Table 88. Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
Table 89. Asymchem Laboratories Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Porton Pharma Corporate Information, Head Office, and Major Competitors
Table 91. Porton Pharma Major Business
Table 92. Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 93. Porton Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. ChemPartner Corporate Information, Head Office, and Major Competitors
Table 95. ChemPartner Major Business
Table 96. ChemPartner Clinical Research Organisation (CRO) Product and Solutions
Table 97. ChemPartner Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 98. Hangzhou Tigermed Corporate Information, Head Office, and Major Competitors
Table 99. Hangzhou Tigermed Major Business
Table 100. Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
Table 101. Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 102. Global Clinical Research Organisation (CRO) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 103. Global Clinical Research Organisation (CRO) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 104. Breakdown of Clinical Research Organisation (CRO) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 105. Clinical Research Organisation (CRO) Players Head Office, Products and Services Provided
Table 106. Clinical Research Organisation (CRO) Mergers & Acquisitions in the Past Five Years
Table 107. Clinical Research Organisation (CRO) New Entrants and Expansion Plans
Table 108. Global Clinical Research Organisation (CRO) Revenue (USD Million) by Type (2017-2022)
Table 109. Global Clinical Research Organisation (CRO) Revenue Share by Type (2017-2022)
Table 110. Global Clinical Research Organisation (CRO) Revenue Forecast by Type (2023-2028)
Table 111. Global Clinical Research Organisation (CRO) Revenue by Application (2017-2022)
Table 112. Global Clinical Research Organisation (CRO) Revenue Forecast by Application (2023-2028)
Table 113. North America Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 114. North America Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 115. North America Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 116. North America Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 117. North America Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (USD Million)
Table 118. North America Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (USD Million)
Table 119. Europe Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 120. Europe Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 121. Europe Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 122. Europe Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 123. Europe Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (USD Million)
Table 124. Europe Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (USD Million)
Table 125. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 126. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 127. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 128. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 129. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Region (2017-2022) & (USD Million)
Table 130. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Region (2023-2028) & (USD Million)
Table 131. South America Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 132. South America Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 133. South America Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 134. South America Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 135. South America Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (USD Million)
Table 136. South America Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (USD Million)
Table 137. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 138. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 139. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 140. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 141. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (USD Million)
Table 142. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Clinical Research Organisation (CRO) Picture
Figure 2. Global Clinical Research Organisation (CRO) Revenue Market Share by Type in 2021
Figure 3. Small molecules
Figure 4. Biologics
Figure 5. Clinical Research Organisation (CRO) Revenue Market Share by Application in 2021
Figure 6. Pharmaceutical Company Picture
Figure 7. Research Institute Picture
Figure 8. Other Picture
Figure 9. Global Clinical Research Organisation (CRO) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Clinical Research Organisation (CRO) Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Clinical Research Organisation (CRO) Revenue Market Share by Region (2017-2028)
Figure 12. Global Clinical Research Organisation (CRO) Revenue Market Share by Region in 2021
Figure 13. North America Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Clinical Research Organisation (CRO) Market Drivers
Figure 19. Clinical Research Organisation (CRO) Market Restraints
Figure 20. Clinical Research Organisation (CRO) Market Trends
Figure 21. Charles River Laboratories Recent Developments and Future Plans
Figure 22. IQVIA Recent Developments and Future Plans
Figure 23. LabCorp Recent Developments and Future Plans
Figure 24. Domainex Recent Developments and Future Plans
Figure 25. Evotec AG Recent Developments and Future Plans
Figure 26. Genscript Biotech Recent Developments and Future Plans
Figure 27. GVK Biosciences Recent Developments and Future Plans
Figure 28. Aurobindo Pharma Recent Developments and Future Plans
Figure 29. Eurofins Scientific Recent Developments and Future Plans
Figure 30. Reprocell Recent Developments and Future Plans
Figure 31. Dalton Pharma Recent Developments and Future Plans
Figure 32. NovAliX Recent Developments and Future Plans
Figure 33. Jubilant Biosys Recent Developments and Future Plans
Figure 34. Lupin Pharmaceuticals Recent Developments and Future Plans
Figure 35. Piramal Pharma Recent Developments and Future Plans
Figure 36. Sun Pharmaceutical Recent Developments and Future Plans
Figure 37. Sai Ganga Panakeia Recent Developments and Future Plans
Figure 38. Vitas Pharma Recent Developments and Future Plans
Figure 39. Pharmaron Beijing Recent Developments and Future Plans
Figure 40. WuXi AppTec Recent Developments and Future Plans
Figure 41. Asymchem Laboratories Recent Developments and Future Plans
Figure 42. Porton Pharma Recent Developments and Future Plans
Figure 43. ChemPartner Recent Developments and Future Plans
Figure 44. Hangzhou Tigermed Recent Developments and Future Plans
Figure 45. Global Clinical Research Organisation (CRO) Revenue Share by Players in 2021
Figure 46. Clinical Research Organisation (CRO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 47. Global Top 3 Players Clinical Research Organisation (CRO) Revenue Market Share in 2021
Figure 48. Global Top 10 Players Clinical Research Organisation (CRO) Revenue Market Share in 2021
Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 50. Global Clinical Research Organisation (CRO) Revenue Share by Type in 2021
Figure 51. Global Clinical Research Organisation (CRO) Market Share Forecast by Type (2023-2028)
Figure 52. Global Clinical Research Organisation (CRO) Revenue Share by Application in 2021
Figure 53. Global Clinical Research Organisation (CRO) Market Share Forecast by Application (2023-2028)
Figure 54. North America Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 55. North America Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 56. North America Clinical Research Organisation (CRO) Revenue Market Share by Country (2017-2028)
Figure 57. United States Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Canada Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Mexico Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Europe Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 61. Europe Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 62. Europe Clinical Research Organisation (CRO) Revenue Market Share by Country (2017-2028)
Figure 63. Germany Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. France Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. United Kingdom Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Russia Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Italy Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Asia-Pacific Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 69. Asia-Pacific Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 70. Asia-Pacific Clinical Research Organisation (CRO) Revenue Market Share by Region (2017-2028)
Figure 71. China Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Japan Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Korea Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. India Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Southeast Asia Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Australia Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South America Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 78. South America Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 79. South America Clinical Research Organisation (CRO) Revenue Market Share by Country (2017-2028)
Figure 80. Brazil Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Argentina Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Middle East and Africa Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Clinical Research Organisation (CRO) Revenue Market Share by Country (2017-2028)
Figure 85. Turkey Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Saudi Arabia Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. UAE Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Methodology
Figure 89. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Clinical Research Organisation (CRO) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Clinical Research Organisation (CRO) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 120

Published Date: 14 Jan 2022

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Clinical Research Organisation (CRO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Clinical Research Organisation (CRO) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical Company accounting for % of the Clinical Research Organisation (CRO) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Small molecules segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Clinical Research Organisation (CRO) include Charles River Laboratories, IQVIA, LabCorp, Domainex, and Evotec AG, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Clinical Research Organisation (CRO) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Small molecules
Biologics

Market segment by Application, can be divided into
Pharmaceutical Company
Research Institute
Other

Market segment by players, this report covers
Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Clinical Research Organisation (CRO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Clinical Research Organisation (CRO), with revenue, gross margin and global market share of Clinical Research Organisation (CRO) from 2019 to 2022.
Chapter 3, the Clinical Research Organisation (CRO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Clinical Research Organisation (CRO) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Clinical Research Organisation (CRO) research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Clinical Research Organisation (CRO)
1.2 Classification of Clinical Research Organisation (CRO) by Type
1.2.1 Overview: Global Clinical Research Organisation (CRO) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Clinical Research Organisation (CRO) Revenue Market Share by Type in 2021
1.2.3 Small molecules
1.2.4 Biologics
1.3 Global Clinical Research Organisation (CRO) Market by Application
1.3.1 Overview: Global Clinical Research Organisation (CRO) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Other
1.4 Global Clinical Research Organisation (CRO) Market Size & Forecast
1.5 Global Clinical Research Organisation (CRO) Market Size and Forecast by Region
1.5.1 Global Clinical Research Organisation (CRO) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Clinical Research Organisation (CRO) Market Size by Region, (2017-2022)
1.5.3 North America Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.5.4 Europe Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.5.6 South America Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Clinical Research Organisation (CRO) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Clinical Research Organisation (CRO) Market Drivers
1.6.2 Clinical Research Organisation (CRO) Market Restraints
1.6.3 Clinical Research Organisation (CRO) Trends Analysis

2 Company Profiles
2.1 Charles River Laboratories
2.1.1 Charles River Laboratories Details
2.1.2 Charles River Laboratories Major Business
2.1.3 Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
2.1.4 Charles River Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Charles River Laboratories Recent Developments and Future Plans
2.2 IQVIA
2.2.1 IQVIA Details
2.2.2 IQVIA Major Business
2.2.3 IQVIA Clinical Research Organisation (CRO) Product and Solutions
2.2.4 IQVIA Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 IQVIA Recent Developments and Future Plans
2.3 LabCorp
2.3.1 LabCorp Details
2.3.2 LabCorp Major Business
2.3.3 LabCorp Clinical Research Organisation (CRO) Product and Solutions
2.3.4 LabCorp Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 LabCorp Recent Developments and Future Plans
2.4 Domainex
2.4.1 Domainex Details
2.4.2 Domainex Major Business
2.4.3 Domainex Clinical Research Organisation (CRO) Product and Solutions
2.4.4 Domainex Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Domainex Recent Developments and Future Plans
2.5 Evotec AG
2.5.1 Evotec AG Details
2.5.2 Evotec AG Major Business
2.5.3 Evotec AG Clinical Research Organisation (CRO) Product and Solutions
2.5.4 Evotec AG Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Evotec AG Recent Developments and Future Plans
2.6 Genscript Biotech
2.6.1 Genscript Biotech Details
2.6.2 Genscript Biotech Major Business
2.6.3 Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
2.6.4 Genscript Biotech Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Genscript Biotech Recent Developments and Future Plans
2.7 GVK Biosciences
2.7.1 GVK Biosciences Details
2.7.2 GVK Biosciences Major Business
2.7.3 GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
2.7.4 GVK Biosciences Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 GVK Biosciences Recent Developments and Future Plans
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
2.8.4 Aurobindo Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Aurobindo Pharma Recent Developments and Future Plans
2.9 Eurofins Scientific
2.9.1 Eurofins Scientific Details
2.9.2 Eurofins Scientific Major Business
2.9.3 Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
2.9.4 Eurofins Scientific Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Eurofins Scientific Recent Developments and Future Plans
2.10 Reprocell
2.10.1 Reprocell Details
2.10.2 Reprocell Major Business
2.10.3 Reprocell Clinical Research Organisation (CRO) Product and Solutions
2.10.4 Reprocell Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Reprocell Recent Developments and Future Plans
2.11 Dalton Pharma
2.11.1 Dalton Pharma Details
2.11.2 Dalton Pharma Major Business
2.11.3 Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
2.11.4 Dalton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Dalton Pharma Recent Developments and Future Plans
2.12 NovAliX
2.12.1 NovAliX Details
2.12.2 NovAliX Major Business
2.12.3 NovAliX Clinical Research Organisation (CRO) Product and Solutions
2.12.4 NovAliX Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 NovAliX Recent Developments and Future Plans
2.13 Jubilant Biosys
2.13.1 Jubilant Biosys Details
2.13.2 Jubilant Biosys Major Business
2.13.3 Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
2.13.4 Jubilant Biosys Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Jubilant Biosys Recent Developments and Future Plans
2.14 Lupin Pharmaceuticals
2.14.1 Lupin Pharmaceuticals Details
2.14.2 Lupin Pharmaceuticals Major Business
2.14.3 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
2.14.4 Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Lupin Pharmaceuticals Recent Developments and Future Plans
2.15 Piramal Pharma
2.15.1 Piramal Pharma Details
2.15.2 Piramal Pharma Major Business
2.15.3 Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
2.15.4 Piramal Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Piramal Pharma Recent Developments and Future Plans
2.16 Sun Pharmaceutical
2.16.1 Sun Pharmaceutical Details
2.16.2 Sun Pharmaceutical Major Business
2.16.3 Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
2.16.4 Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Sun Pharmaceutical Recent Developments and Future Plans
2.17 Sai Ganga Panakeia
2.17.1 Sai Ganga Panakeia Details
2.17.2 Sai Ganga Panakeia Major Business
2.17.3 Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
2.17.4 Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Sai Ganga Panakeia Recent Developments and Future Plans
2.18 Vitas Pharma
2.18.1 Vitas Pharma Details
2.18.2 Vitas Pharma Major Business
2.18.3 Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
2.18.4 Vitas Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Vitas Pharma Recent Developments and Future Plans
2.19 Pharmaron Beijing
2.19.1 Pharmaron Beijing Details
2.19.2 Pharmaron Beijing Major Business
2.19.3 Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
2.19.4 Pharmaron Beijing Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Pharmaron Beijing Recent Developments and Future Plans
2.20 WuXi AppTec
2.20.1 WuXi AppTec Details
2.20.2 WuXi AppTec Major Business
2.20.3 WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
2.20.4 WuXi AppTec Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 WuXi AppTec Recent Developments and Future Plans
2.21 Asymchem Laboratories
2.21.1 Asymchem Laboratories Details
2.21.2 Asymchem Laboratories Major Business
2.21.3 Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
2.21.4 Asymchem Laboratories Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Asymchem Laboratories Recent Developments and Future Plans
2.22 Porton Pharma
2.22.1 Porton Pharma Details
2.22.2 Porton Pharma Major Business
2.22.3 Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
2.22.4 Porton Pharma Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Porton Pharma Recent Developments and Future Plans
2.23 ChemPartner
2.23.1 ChemPartner Details
2.23.2 ChemPartner Major Business
2.23.3 ChemPartner Clinical Research Organisation (CRO) Product and Solutions
2.23.4 ChemPartner Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23.5 ChemPartner Recent Developments and Future Plans
2.24 Hangzhou Tigermed
2.24.1 Hangzhou Tigermed Details
2.24.2 Hangzhou Tigermed Major Business
2.24.3 Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
2.24.4 Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24.5 Hangzhou Tigermed Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Clinical Research Organisation (CRO) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Clinical Research Organisation (CRO) Players Market Share in 2021
3.2.2 Top 10 Clinical Research Organisation (CRO) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Clinical Research Organisation (CRO) Players Head Office, Products and Services Provided
3.4 Clinical Research Organisation (CRO) Mergers & Acquisitions
3.5 Clinical Research Organisation (CRO) New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Clinical Research Organisation (CRO) Revenue and Market Share by Type (2017-2022)
4.2 Global Clinical Research Organisation (CRO) Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
5.1 Global Clinical Research Organisation (CRO) Revenue Market Share by Application (2017-2022)
5.2 Global Clinical Research Organisation (CRO) Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
6.1 North America Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
6.2 North America Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
6.3 North America Clinical Research Organisation (CRO) Market Size by Country
6.3.1 North America Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
6.3.2 United States Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
6.3.3 Canada Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
6.3.4 Mexico Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
7.1 Europe Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
7.2 Europe Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
7.3 Europe Clinical Research Organisation (CRO) Market Size by Country
7.3.1 Europe Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
7.3.2 Germany Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
7.3.3 France Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
7.3.5 Russia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
7.3.6 Italy Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
8.2 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
8.3 Asia-Pacific Clinical Research Organisation (CRO) Market Size by Region
8.3.1 Asia-Pacific Clinical Research Organisation (CRO) Revenue by Region (2017-2028)
8.3.2 China Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.3 Japan Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.4 South Korea Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.5 India Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
8.3.7 Australia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
9.1 South America Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
9.2 South America Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
9.3 South America Clinical Research Organisation (CRO) Market Size by Country
9.3.1 South America Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
9.3.2 Brazil Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
9.3.3 Argentina Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Type (2017-2028)
10.2 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Application (2017-2028)
10.3 Middle East & Africa Clinical Research Organisation (CRO) Market Size by Country
10.3.1 Middle East & Africa Clinical Research Organisation (CRO) Revenue by Country (2017-2028)
10.3.2 Turkey Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)
10.3.4 UAE Clinical Research Organisation (CRO) Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Clinical Research Organisation (CRO) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Clinical Research Organisation (CRO) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Clinical Research Organisation (CRO) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Clinical Research Organisation (CRO) Revenue (USD Million) by Region (2017-2022)
Table 5. Global Clinical Research Organisation (CRO) Revenue Market Share by Region (2023-2028)
Table 6. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Charles River Laboratories Major Business
Table 8. Charles River Laboratories Clinical Research Organisation (CRO) Product and Solutions
Table 9. Charles River Laboratories Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. IQVIA Corporate Information, Head Office, and Major Competitors
Table 11. IQVIA Major Business
Table 12. IQVIA Clinical Research Organisation (CRO) Product and Solutions
Table 13. IQVIA Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. LabCorp Corporate Information, Head Office, and Major Competitors
Table 15. LabCorp Major Business
Table 16. LabCorp Clinical Research Organisation (CRO) Product and Solutions
Table 17. LabCorp Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Domainex Corporate Information, Head Office, and Major Competitors
Table 19. Domainex Major Business
Table 20. Domainex Clinical Research Organisation (CRO) Product and Solutions
Table 21. Domainex Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Evotec AG Corporate Information, Head Office, and Major Competitors
Table 23. Evotec AG Major Business
Table 24. Evotec AG Clinical Research Organisation (CRO) Product and Solutions
Table 25. Evotec AG Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Genscript Biotech Corporate Information, Head Office, and Major Competitors
Table 27. Genscript Biotech Major Business
Table 28. Genscript Biotech Clinical Research Organisation (CRO) Product and Solutions
Table 29. Genscript Biotech Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. GVK Biosciences Corporate Information, Head Office, and Major Competitors
Table 31. GVK Biosciences Major Business
Table 32. GVK Biosciences Clinical Research Organisation (CRO) Product and Solutions
Table 33. GVK Biosciences Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Aurobindo Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Aurobindo Pharma Major Business
Table 36. Aurobindo Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 37. Aurobindo Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 39. Eurofins Scientific Major Business
Table 40. Eurofins Scientific Clinical Research Organisation (CRO) Product and Solutions
Table 41. Eurofins Scientific Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Reprocell Corporate Information, Head Office, and Major Competitors
Table 43. Reprocell Major Business
Table 44. Reprocell Clinical Research Organisation (CRO) Product and Solutions
Table 45. Reprocell Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Dalton Pharma Corporate Information, Head Office, and Major Competitors
Table 47. Dalton Pharma Major Business
Table 48. Dalton Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 49. Dalton Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. NovAliX Corporate Information, Head Office, and Major Competitors
Table 51. NovAliX Major Business
Table 52. NovAliX Clinical Research Organisation (CRO) Product and Solutions
Table 53. NovAliX Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Jubilant Biosys Corporate Information, Head Office, and Major Competitors
Table 55. Jubilant Biosys Major Business
Table 56. Jubilant Biosys Clinical Research Organisation (CRO) Product and Solutions
Table 57. Jubilant Biosys Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Lupin Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. Lupin Pharmaceuticals Major Business
Table 60. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Product and Solutions
Table 61. Lupin Pharmaceuticals Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Piramal Pharma Corporate Information, Head Office, and Major Competitors
Table 63. Piramal Pharma Major Business
Table 64. Piramal Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 65. Piramal Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 67. Sun Pharmaceutical Major Business
Table 68. Sun Pharmaceutical Clinical Research Organisation (CRO) Product and Solutions
Table 69. Sun Pharmaceutical Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Sai Ganga Panakeia Corporate Information, Head Office, and Major Competitors
Table 71. Sai Ganga Panakeia Major Business
Table 72. Sai Ganga Panakeia Clinical Research Organisation (CRO) Product and Solutions
Table 73. Sai Ganga Panakeia Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Vitas Pharma Corporate Information, Head Office, and Major Competitors
Table 75. Vitas Pharma Major Business
Table 76. Vitas Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 77. Vitas Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Pharmaron Beijing Corporate Information, Head Office, and Major Competitors
Table 79. Pharmaron Beijing Major Business
Table 80. Pharmaron Beijing Clinical Research Organisation (CRO) Product and Solutions
Table 81. Pharmaron Beijing Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. WuXi AppTec Corporate Information, Head Office, and Major Competitors
Table 83. WuXi AppTec Major Business
Table 84. WuXi AppTec Clinical Research Organisation (CRO) Product and Solutions
Table 85. WuXi AppTec Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Asymchem Laboratories Corporate Information, Head Office, and Major Competitors
Table 87. Asymchem Laboratories Major Business
Table 88. Asymchem Laboratories Clinical Research Organisation (CRO) Product and Solutions
Table 89. Asymchem Laboratories Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Porton Pharma Corporate Information, Head Office, and Major Competitors
Table 91. Porton Pharma Major Business
Table 92. Porton Pharma Clinical Research Organisation (CRO) Product and Solutions
Table 93. Porton Pharma Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. ChemPartner Corporate Information, Head Office, and Major Competitors
Table 95. ChemPartner Major Business
Table 96. ChemPartner Clinical Research Organisation (CRO) Product and Solutions
Table 97. ChemPartner Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 98. Hangzhou Tigermed Corporate Information, Head Office, and Major Competitors
Table 99. Hangzhou Tigermed Major Business
Table 100. Hangzhou Tigermed Clinical Research Organisation (CRO) Product and Solutions
Table 101. Hangzhou Tigermed Clinical Research Organisation (CRO) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 102. Global Clinical Research Organisation (CRO) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 103. Global Clinical Research Organisation (CRO) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 104. Breakdown of Clinical Research Organisation (CRO) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 105. Clinical Research Organisation (CRO) Players Head Office, Products and Services Provided
Table 106. Clinical Research Organisation (CRO) Mergers & Acquisitions in the Past Five Years
Table 107. Clinical Research Organisation (CRO) New Entrants and Expansion Plans
Table 108. Global Clinical Research Organisation (CRO) Revenue (USD Million) by Type (2017-2022)
Table 109. Global Clinical Research Organisation (CRO) Revenue Share by Type (2017-2022)
Table 110. Global Clinical Research Organisation (CRO) Revenue Forecast by Type (2023-2028)
Table 111. Global Clinical Research Organisation (CRO) Revenue by Application (2017-2022)
Table 112. Global Clinical Research Organisation (CRO) Revenue Forecast by Application (2023-2028)
Table 113. North America Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 114. North America Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 115. North America Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 116. North America Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 117. North America Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (USD Million)
Table 118. North America Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (USD Million)
Table 119. Europe Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 120. Europe Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 121. Europe Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 122. Europe Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 123. Europe Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (USD Million)
Table 124. Europe Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (USD Million)
Table 125. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 126. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 127. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 128. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 129. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Region (2017-2022) & (USD Million)
Table 130. Asia-Pacific Clinical Research Organisation (CRO) Revenue by Region (2023-2028) & (USD Million)
Table 131. South America Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 132. South America Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 133. South America Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 134. South America Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 135. South America Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (USD Million)
Table 136. South America Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (USD Million)
Table 137. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Type (2017-2022) & (USD Million)
Table 138. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Type (2023-2028) & (USD Million)
Table 139. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Application (2017-2022) & (USD Million)
Table 140. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Application (2023-2028) & (USD Million)
Table 141. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Country (2017-2022) & (USD Million)
Table 142. Middle East & Africa Clinical Research Organisation (CRO) Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Clinical Research Organisation (CRO) Picture
Figure 2. Global Clinical Research Organisation (CRO) Revenue Market Share by Type in 2021
Figure 3. Small molecules
Figure 4. Biologics
Figure 5. Clinical Research Organisation (CRO) Revenue Market Share by Application in 2021
Figure 6. Pharmaceutical Company Picture
Figure 7. Research Institute Picture
Figure 8. Other Picture
Figure 9. Global Clinical Research Organisation (CRO) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Clinical Research Organisation (CRO) Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Clinical Research Organisation (CRO) Revenue Market Share by Region (2017-2028)
Figure 12. Global Clinical Research Organisation (CRO) Revenue Market Share by Region in 2021
Figure 13. North America Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Clinical Research Organisation (CRO) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Clinical Research Organisation (CRO) Market Drivers
Figure 19. Clinical Research Organisation (CRO) Market Restraints
Figure 20. Clinical Research Organisation (CRO) Market Trends
Figure 21. Charles River Laboratories Recent Developments and Future Plans
Figure 22. IQVIA Recent Developments and Future Plans
Figure 23. LabCorp Recent Developments and Future Plans
Figure 24. Domainex Recent Developments and Future Plans
Figure 25. Evotec AG Recent Developments and Future Plans
Figure 26. Genscript Biotech Recent Developments and Future Plans
Figure 27. GVK Biosciences Recent Developments and Future Plans
Figure 28. Aurobindo Pharma Recent Developments and Future Plans
Figure 29. Eurofins Scientific Recent Developments and Future Plans
Figure 30. Reprocell Recent Developments and Future Plans
Figure 31. Dalton Pharma Recent Developments and Future Plans
Figure 32. NovAliX Recent Developments and Future Plans
Figure 33. Jubilant Biosys Recent Developments and Future Plans
Figure 34. Lupin Pharmaceuticals Recent Developments and Future Plans
Figure 35. Piramal Pharma Recent Developments and Future Plans
Figure 36. Sun Pharmaceutical Recent Developments and Future Plans
Figure 37. Sai Ganga Panakeia Recent Developments and Future Plans
Figure 38. Vitas Pharma Recent Developments and Future Plans
Figure 39. Pharmaron Beijing Recent Developments and Future Plans
Figure 40. WuXi AppTec Recent Developments and Future Plans
Figure 41. Asymchem Laboratories Recent Developments and Future Plans
Figure 42. Porton Pharma Recent Developments and Future Plans
Figure 43. ChemPartner Recent Developments and Future Plans
Figure 44. Hangzhou Tigermed Recent Developments and Future Plans
Figure 45. Global Clinical Research Organisation (CRO) Revenue Share by Players in 2021
Figure 46. Clinical Research Organisation (CRO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 47. Global Top 3 Players Clinical Research Organisation (CRO) Revenue Market Share in 2021
Figure 48. Global Top 10 Players Clinical Research Organisation (CRO) Revenue Market Share in 2021
Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 50. Global Clinical Research Organisation (CRO) Revenue Share by Type in 2021
Figure 51. Global Clinical Research Organisation (CRO) Market Share Forecast by Type (2023-2028)
Figure 52. Global Clinical Research Organisation (CRO) Revenue Share by Application in 2021
Figure 53. Global Clinical Research Organisation (CRO) Market Share Forecast by Application (2023-2028)
Figure 54. North America Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 55. North America Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 56. North America Clinical Research Organisation (CRO) Revenue Market Share by Country (2017-2028)
Figure 57. United States Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Canada Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Mexico Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Europe Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 61. Europe Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 62. Europe Clinical Research Organisation (CRO) Revenue Market Share by Country (2017-2028)
Figure 63. Germany Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. France Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. United Kingdom Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Russia Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Italy Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Asia-Pacific Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 69. Asia-Pacific Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 70. Asia-Pacific Clinical Research Organisation (CRO) Revenue Market Share by Region (2017-2028)
Figure 71. China Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Japan Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Korea Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. India Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Southeast Asia Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Australia Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South America Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 78. South America Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 79. South America Clinical Research Organisation (CRO) Revenue Market Share by Country (2017-2028)
Figure 80. Brazil Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Argentina Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Middle East and Africa Clinical Research Organisation (CRO) Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Clinical Research Organisation (CRO) Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Clinical Research Organisation (CRO) Revenue Market Share by Country (2017-2028)
Figure 85. Turkey Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Saudi Arabia Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. UAE Clinical Research Organisation (CRO) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Methodology
Figure 89. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Charles River Laboratories
IQVIA
LabCorp
Domainex
Evotec AG
Genscript Biotech
GVK Biosciences
Aurobindo Pharma
Eurofins Scientific
Reprocell
Dalton Pharma
NovAliX
Jubilant Biosys
Lupin Pharmaceuticals
Piramal Pharma
Sun Pharmaceutical
Sai Ganga Panakeia
Vitas Pharma
Pharmaron Beijing
WuXi AppTec
Asymchem Laboratories
Porton Pharma
ChemPartner
Hangzhou Tigermed
jiaGou

Add To Cart

gouMai

Buy Now